Issue 19 | Spring | Primary Immune Deficiency Treatment Consortium

Skip to main content

Search

Join Our Contact Registry

Header Social Media

Main navigation

Our Research
Patient and Families
Researchers and Clinicians
- Funding Opportunities
Early Stage Investigators
News and Events
- Latest News
- Newsletters
About Us

An NIH-Funded Rare Diseases Clinical Research Network Consortium

Mon, 06/24/2024 - 10:29

19

Document

Attachment	Size
PIDTC-Newsletter-Issue-19_2024.03.22.pdf	9.19 MB

Primary Immune Deficiency Treatment Consortium

Image

PIDTC Newsletter Issue 19.

Footer menu

Web Policies
Rare Diseases Clinical Research Network
Genetic and Rare Diseases Information Center
Members Login
Contact Us

The Primary Immune Deficiency Treatment Consortium (PIDTC) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). PIDTC is funded under grant number U54AI082973 as a collaboration between NCATS and the National Institute of Allergy and Infectious Diseases (NIAID). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke NINDS) under grant number TR002818. The content of this website is solely the responsibility of the PIDTC administrative coordinating center at University of California, San Francisco and does not necessarily represent the official views of the NIH.

social media